{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T08:19:46Z","timestamp":1782375586377,"version":"3.54.5"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2017,11,27]],"date-time":"2017-11-27T00:00:00Z","timestamp":1511740800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Science and Technology, Taiwan (TW)","award":["MOST 105-2628-B-075-006-MY2"],"award-info":[{"award-number":["MOST 105-2628-B-075-006-MY2"]}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"crossref","award":["V105B-007"],"award-info":[{"award-number":["V105B-007"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"crossref","award":["V106B-021"],"award-info":[{"award-number":["V106B-021"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0188552","type":"journal-article","created":{"date-parts":[[2017,11,27]],"date-time":"2017-11-27T18:46:15Z","timestamp":1511808375000},"page":"e0188552","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Risk of recurrence in chronic hepatitis B patients developing hepatocellular carcinoma with antiviral secondary prevention failure"],"prefix":"10.1371","volume":"12","author":[{"given":"I-Cheng","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gar-Yang","family":"Chau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chen","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yee","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teh-Ia","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Wei","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Chieh","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Chih","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5241-5425","authenticated-orcid":true,"given":"Yi-Hsiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,11,27]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"LA Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","article-title":"Epidemiology of viral hepatitis and hepatocellular carcinoma","volume":"142","author":"HB El-Serag","year":"2012","journal-title":"Gastroenterology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1001\/jama.2013.276701","article-title":"Thirty-year outcomes of the national hepatitis B immunization program in Taiwan","volume":"310","author":"CJ Chiang","year":"2013","journal-title":"JAMA"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","article-title":"Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013","volume":"386","author":"A Schweitzer","year":"2015","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/hep.28156","article-title":"AASLD guidelines for treatment of chronic hepatitis B","volume":"63","author":"NA Terrault","year":"2016","journal-title":"Hepatology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"EASL clinical practice guidelines: Management of chronic hepatitis B virus infection","volume":"57","year":"2012","journal-title":"Journal of hepatology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jhep.2010.02.035","article-title":"Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review","volume":"53","author":"GV Papatheodoridis","year":"2010","journal-title":"Journal of hepatology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1053\/j.gastro.2014.03.048","article-title":"Association of nucleos(t)ide analogue therapy with reduced risk of hepatocellular carcinoma in patients with chronic hepatitis B: a nationwide cohort study","volume":"147","author":"CY Wu","year":"2014","journal-title":"Gastroenterology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1136\/gut.2010.221846","article-title":"Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study","volume":"60","author":"GV Papatheodoridis","year":"2011","journal-title":"Gut"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1136\/gutjnl-2013-306409","article-title":"Patients with chronic hepatitis B treated with oral antiviral therapy retain a higher risk for HCC compared with patients with inactive stage disease","volume":"63","author":"JY Cho","year":"2014","journal-title":"Gut"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1002\/hep.26301","article-title":"Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients with liver cirrhosis","volume":"58","author":"GL Wong","year":"2013","journal-title":"Hepatology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jhep.2014.08.045","article-title":"Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir","volume":"62","author":"GV Papatheodoridis","year":"2015","journal-title":"Journal of hepatology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jhep.2015.01.002","article-title":"Risk of hepatocellular carcinoma in chronic hepatitis B: assessment and modification with current antiviral therapy","volume":"62","author":"GV Papatheodoridis","year":"2015","journal-title":"J Hepatol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1093\/jac\/dku041","article-title":"Determinants of hepatocellular carcinoma in cirrhotic patients treated with nucleos(t)ide analogues for chronic hepatitis B","volume":"69","author":"YC Hsu","year":"2014","journal-title":"The Journal of antimicrobial chemotherapy"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/ajg.2014.145","article-title":"Effect of virological response to entecavir on the development of hepatocellular carcinoma in hepatitis B viral cirrhotic patients: comparison between compensated and decompensated cirrhosis","volume":"109","author":"SS Kim","year":"2014","journal-title":"The American journal of gastroenterology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma","volume":"56","year":"2012","journal-title":"Journal of hepatology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1002\/ijc.28311","article-title":"Serum interferon gamma level predicts recurrence in hepatocellular carcinoma patients after curative treatments","volume":"133","author":"IC Lee","year":"2013","journal-title":"International journal of cancer Journal international du cancer"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1478-3231.2005.01081.x","article-title":"Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area","volume":"25","author":"YH Huang","year":"2005","journal-title":"Liver Int"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.jhep.2009.07.009","article-title":"Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma","volume":"51","author":"JC Wu","year":"2009","journal-title":"Journal of hepatology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e66457","DOI":"10.1371\/journal.pone.0066457","article-title":"The Influence of Hepatitis B Viral Load and Pre-S Deletion Mutations on Post-Operative Recurrence of Hepatocellular Carcinoma and the Tertiary Preventive Effects by Anti-Viral Therapy","volume":"8","author":"CW Su","year":"2013","journal-title":"PloS one"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/j.1365-2036.2011.04634.x","article-title":"Meta-analysis: the efficacy of anti-viral therapy in prevention of recurrence after curative treatment of chronic hepatitis B-related hepatocellular carcinoma","volume":"33","author":"JS Wong","year":"2011","journal-title":"Alimentary pharmacology & therapeutics"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1001\/2012.jama.11975","article-title":"Association between nucleoside analogues and risk of hepatitis B virus-related hepatocellular carcinoma recurrence following liver resection","volume":"308","author":"CY Wu","year":"2012","journal-title":"JAMA"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1200\/JCO.2012.48.5896","article-title":"Effect of antiviral treatment with nucleotide\/nucleoside analogs on postoperative prognosis of hepatitis B virus-related hepatocellular carcinoma: a two-stage longitudinal clinical study","volume":"31","author":"J Yin","year":"2013","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/SLA.0000000000000858","article-title":"Antiviral therapy improves postoperative survival in patients with hepatocellular carcinoma: a randomized controlled trial","volume":"261","author":"G Huang","year":"2015","journal-title":"Annals of surgery"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/apt.13034","article-title":"Antiviral therapy improves post-hepatectomy survival in patients with hepatitis B virus-related hepatocellular carcinoma: a prospective-retrospective study","volume":"41","author":"CC Chong","year":"2015","journal-title":"Alimentary pharmacology & therapeutics"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/apt.13548","article-title":"Oral nucleos(t)ide analogues reduce recurrence and death in chronic hepatitis B-related hepatocellular carcinoma","volume":"43","author":"GL Wong","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s12072-012-9365-4","article-title":"Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update","volume":"6","author":"YF Liaw","year":"2012","journal-title":"Hepatology international"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: an update","volume":"53","author":"J Bruix","year":"2011","journal-title":"Hepatology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","article-title":"Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade","volume":"33","author":"PJ Johnson","year":"2015","journal-title":"J Clin Oncol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/hep.27382","article-title":"Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis-4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: a systemic review and meta-analysis","volume":"61","author":"G Xiao","year":"2015","journal-title":"Hepatology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/MCG.0b013e3181dd5357","article-title":"Comparative analysis of noninvasive models to predict early liver fibrosis in hepatitis B e Antigen-negative Chronic Hepatitis B","volume":"45","author":"IC Lee","year":"2011","journal-title":"Journal of clinical gastroenterology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"K Ishak","year":"1995","journal-title":"J Hepatol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1016\/j.jhep.2016.02.021","article-title":"Mechanisms of HBV-induced hepatocellular carcinoma","volume":"64","author":"M Levrero","year":"2016","journal-title":"J Hepatol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.clnu.2011.05.001","article-title":"Impact of body mass index and viral load on liver histology in hepatitis B e antigen-negative chronic hepatitis B","volume":"30","author":"IC Lee","year":"2011","journal-title":"Clin Nutr"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"5576","DOI":"10.1200\/JCO.2008.16.1075","article-title":"Body-mass index and progression of hepatitis B: a population-based cohort study in men","volume":"26","author":"MW Yu","year":"2008","journal-title":"J Clin Oncol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/01.sla.0000197706.21803.a1","article-title":"Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications","volume":"243","author":"N Portolani","year":"2006","journal-title":"Ann Surg"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1245\/s10434-014-3621-x","article-title":"HBV DNA and HBsAg levels as risk predictors of early and late recurrence after curative resection of HBV-related hepatocellular carcinoma","volume":"21","author":"W Sohn","year":"2014","journal-title":"Annals of surgical oncology"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/hep.23785","article-title":"Long-term entecavir therapy results in the reversal of fibrosis\/cirrhosis and continued histological improvement in patients with chronic hepatitis B","volume":"52","author":"TT Chang","year":"2010","journal-title":"Hepatology"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0140-6736(12)61425-1","article-title":"Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study","volume":"381","author":"P Marcellin","year":"2013","journal-title":"Lancet"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/j.gastro.2013.01.002","article-title":"Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma","volume":"144","author":"V Hernandez-Gea","year":"2013","journal-title":"Gastroenterology"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jhep.2015.11.012","article-title":"Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients","volume":"64","author":"WR Kim","year":"2016","journal-title":"J Hepatol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0188552","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T03:07:42Z","timestamp":1719630462000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0188552"}},"subtitle":[],"editor":[{"given":"Yujin","family":"Hoshida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,11,27]]},"references-count":41,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2017,11,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0188552","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,27]]}}}